European Association of Urology
Guidelines
Education & Events
Join our events Join our events
On-demand education Learn at your own pace
Scholarships Enrich your capabilities
Exchange Programmes Urology beyond Europe
Education Educational Platforms Talent Incubator Programme Accreditation
Science & Publications
Publications Our publications
Research & Science Passionate about research?
About
Who we are Our mission and history
Our Board and Offices How we work
Join the EAU Find out about membership
Vacancies Contact
Guidelines

Muscle-invasive and Metastatic Bladder Cancer

Want to read the guideline in your own time? Download the PDF

Download full guideline

Looking for a quick overview? Check the pocket guidelines.

Download pocket guidelines
Full text guidelineSummary of ChangesPublications & AppendicesPanelRelated content
No results found
  • E-course: EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer
  • Cheat Sheet: Epidemiology, pathology and diagnosis
  • Cheat Sheet: Disease Management I
  • Cheat Sheet: Disease Management II
  • Cheat Sheet: Disease Management III

Related content

We offer education, events and other related content to give you a better understanding of the Muscle-invasive and Metastatic Bladder Cancer guidelines.

E-course: EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer

This course compiles the most recent clinical guidelines edited by the EAU in relation to Muscle-invasive and Metastatic Bladder Cancer. Muscle-invasive and Metastatic Bladder Cancer course is divided in 2 learning units. Each Learning Unit consists of multiple choice questions that you can answer by navigating to the corresponding chapter of the Muscle-invasive and Metastatic Bladder Cancer guideline. The questions are offered for self-assessment of your knowledge of the EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer.

Start learning

Cheat Sheet: Epidemiology, pathology and diagnosis

Bladder cancer (BC) is the 7th most commonly diagnosed cancer in males. Incidence and mortality rates vary across countries. For about 35% of patients, bladder cancer is either muscle-invasive or metastatic at disease presentation. Non-muscle invasive disease can progress to become muscle-invasive bladder cancer later on in the disease course.

Download pdf

Cheat Sheet: Disease Management I

The standard treatment for patients with urothelial muscle invasive bladder cancer (MIBC) is radical cystectomy (RC). However, RC only provides 5-year survival in about 50% of patients. Review the Guidelines on disease management in this sheet.

Download pdf

Cheat Sheet: Disease Management II

This Cheat Sheet discusses various strategies for urinary diversion following radical cystectomy, highlighting the use of the ileum, colon, and appendix. The document emphasizes the importance of the 'Fast tract'/ERAS protocol in improving post-operative outcomes and discusses the management of locally-advanced disease, including palliative treatments and bladder-sparing options like transurethral resection, external beam radiotherapy, chemotherapy, and trimodality bladder-preserving treatment.

Download pdf

Cheat Sheet: Disease Management III

This document covers adjuvant chemotherapy and immunotherapy roles, recent advancements in metastatic UC treatment, and combination therapy standards like EV + Pembrolizumab. Key points include eligibility criteria, survival outcomes, and managing immune-related adverse effects.

Download pdf
About EAU
  • Who we are
  • How we work
  • Become a member
Services
  • MyEAU
  • Congress registrations
  • Abstract submission
Media
  • EAU News
  • EAU Newsletter
  • EAU Press Releases
Contact
  • EAU Central Office
    PO Box 30016
    NL-6803 AA ARNHEM
    The Netherlands

  • Contact us
About EAU
Who we areHow we workBecome a member
Services
MyEAUCongress registrationsAbstract submission
Media
EAU NewsEAU NewsletterEAU Press Releases
Contact

EAU Central Office
PO Box 30016
NL-6803 AA ARNHEM
The Netherlands

Contact us
European Association of Urology
Privacy PolicyDisclaimer